A dangerous fungus that was first identified in Asia was found in two cities, Washington DC and Dallas, Texas.

The said newly identified fungus is reportedly resistant to all drugs.

Hospitals and patients are in danger once this fungus reaches them. And when it enters the bloodstream it can be very deadly.

Here’s an excerpt from Stat News report:

For the first time, researchers have reported cases of people carrying or infected with strains of the dangerous fungus Candida Auris that were resistant to all classes of antifungal drugs before any treatment, the Centers for Disease Control and Prevention said Thursday. The agency also reported evidence of some transmission of the strains within health facilities.

Candida Auris, or C. Auris, which was first seen in 2009, has been highly resistant to the few available treatment options for several years, leaving people who treat and study fungal diseases concerned about the toll this superbug could take, particularly on severely ill patients. That there are now so-called pan-resistant cases in people who had never been treated with antifungal drugs is particularly unnerving, experts said.

The CDC reported on five cases, three in Washington, D.C., and two in Texas. In both locations, the cases were clustered within facilities. The facilities were not identified, but the fungus is most commonly diagnosed in very sick people who are in specialized long-term facilities.

And according to the CDC report:

Candida Auris is an emerging fungus that presents a serious global health threat. CDC is concerned about C. Auris for three main reasons:

  1. It is often multidrug-resistant, meaning that it is resistant to multiple antifungal drugs commonly used to treat Candida infections. Some strains are resistant to all three available classes of antifungals.

  2. It is difficult to identify with standard laboratory methods, and it can be misidentified in labs without specific technology. Misidentification may lead to inappropriate management.

  3. It has caused outbreaks in healthcare settings. For this reason, it is important to quickly identify C. Auris in a hospitalized patient so that healthcare facilities can take special precautions to stop its spread.

Sources: The Gateway Pundit, Stat News, CDC

Leave a Reply

Your email address will not be published. Required fields are marked *